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A novel and rapid method for identifying and quantifying 3,5,3=-triiodothyronine (T3) and
3,3=,5=-triiodothyronine (rT3; reverse T3) has been introduced using electrospray ionization
tandem mass spectrometry (ESI-MS/MS). MS2 spectra in either negative ionization mode or
positive ionization mode can be used to differentiate T3 and rT3. Quantification of the T3 and
rT3 isomers under the negative ionization mode is also achieved without prior separation by
HPLC. (J Am Soc Mass Spectrom 2005, 16, 1781–1786) © 2005 American Society for Mass
SpectrometryThe thyroid hormones, 3,5,3=,5=-tetraiodothyronine(T4), 3,5,3=-triiodothyronine (T3), and 3,3=,5=- tri-iodothyronine (rT3; reverse T3) (Figure 1), are
important in regulating a number of biological pro-
cesses, including growth and development, carbohy-
drate metabolism, oxygen consumption, protein syn-
thesis, and fetal neurodevelopment [1]. T4 is secreted by
the thyroid gland. Both T3 and rT3, triiodo analogues of
T4, are mainly produced by peripheral deiodination of
T4 [2].
T3 is considered to be the most metabolically active
thyroid hormone. Although some T3 is produced in the
thyroid, 80 –90% is generated outside the thyroid, pri-
marily by removal of an iodine atom from the outer
phenolic ring of T4 in the liver and kidneys [3, 4]. The
pituitary and nervous systems are also capable of
converting T4 to T3, and thus these tissues are not
dependent on T3 produced in the liver or kidney.
Alternatively, T4 can be converted to rT3 by removal of
an iodine atom from the tyrosine ring of T4. Under
normal conditions, 45–50% of the daily production of
T4 is transformed into rT3 [3]. rT3 is currently thought
not to have hormonal activity itself, but rather to act as
a major competitive inhibitor of T3 activity at the
cellular level [5]. There are three known deiodinases in
vertebrates. D1, found mostly in thyroid, liver, and
kidney but widely expressed in other tissues also, is
selenium-sensitive and can catalyze both outer and
inner ring deiodinations. Its preferred substrate is rT3,
which it further deiodinates to 3,3=-diiodothyronine
(3,3=-T2) by outer ring deiodination, but it can also
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doi:10.1016/j.jasms.2005.06.017convert T4 to T3 or to rT3 [6]. D2, found mainly in
pituitary, brain, brown adipose tissue, and placenta,
catalyzes only outer ring deiodinations, and its pre-
ferred substrate is T4. Thus, its main function is to
produce T3 locally for use in specific tissues [6]. D3,
found mainly in liver, brain, and placenta, is also
selenium-dependent, but catalyzes only inner ring deio-
dinations. It primarily inactivates T4, converting it to
rT3, and T3, converting it to 3,3=-T2 [6]. Sulfations of T4,
T3, or rT3 can also affect their responsiveness to the
various deiodinases [6]. In addition, experimental data
suggest that rT3 may inhibit deiodinases, thereby di-
rectly interfering with the generation of T3 from T4, or
with subsequent breakdown of T3 [5–7]. Thus, the
molar ratio of T3 to rT3 is an important diagnostic
marker for the metabolism and function of thyroid
hormones in clinical chemistry.
Total serum T3 and rT3 measurements are routinely
performed using methods based upon immunoassays,
an approach with high sensitivity, but which lacks
specificity for many analytes [8 –11]. In recent years,
mass spectrometry (MS) techniques have attracted at-
tention for the analysis of T4 and T3 because they
provide high mass accuracy, structural information,
and the ability to quantify the hormones [12–19].
A recently developed methodology shows that elec-
trospray ionization tandem mass spectrometry (ESI-
MS/MS) can be used for identification and quantifica-
tion of mixtures of isomers, such as chondroitin sulfate
disaccharides, diastereomeric hexosamine monosaccha-
rides, and diastereomeric N-acetylhexosamines isomers
[20 –22]. However, quantification of T3 and rT3 isomers
in mixtures based on the relative abundance of frag-
ment ions in MS2 spectra has not been reported so far.
In this study, we used ESI-MS/MS techniques to dis-
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without prior separation by HPLC.
Experimental
Materials
Standards of T3 and rT3 were purchased from Sigma
(St. Louis, MO). Human serum containing natural levels
of thyroxine was purchased from Sigma. Acetic acid
and ammonium hydroxide were purchased from Fisher
(Santa Clara, CA). Solvents used were of HPLC grade
and purchased from Fisher. Oasis MAX SPE™ car-
tridges were purchased from Waters (Milford, MA).
Ultra free-MC centrifugal filter units (5000 NMWL,
Millipore) were purchased from Fisher (Pittsburgh,
PA).
Preparation of T3 and rT3 Samples
Initially, stock solutions of T3 and rT3 were made in
methanol to give a concentration of 1 mg/mL. Standard
solutions were made by diluting stock solutions to 1
ng/L in methanol. Standard solutions were stored at
20 °C and wrapped with aluminum foil.
For positive ionization mode analysis, the diluting
solution consists of 2 mL/L acetic acid in methanol-
water (55:45 by volume). For negative ionization mode
analysis, the diluting solution consists of 2 mL/L am-
monium hydroxide in methanol-water (55:45 by vol-
ume) [12, 13]. For qualitative analysis, 10 L of each
standard solution was diluted by adding 90 L of the
Figure 1. Chemical structures of T4, T3, and rT3.appropriate dilution solution.Preparation of Human Serum Using an Oasis
MAX SPE Cartridge
Human serum was thawed at room-temperature. 0.5
mL of the serum was made alkaline with 30 L of 2%
ammonium hydroxide, diluted to a total volume of 1
mL with water, and then applied to an Oasis MAX 3 cc
(60 mg) SPE cartridge which had been preconditioned
by washing consecutively with 3 mL of methanol and
then 3 mL water. After the loading step, the first
effluent from the cartridge was collected and reloaded
to obtain high percentage recovery. The cartridge was
then washed with 2 mL of a 2% aqueous solution of
ammonium hydroxide followed by 2 mL of methanol.
The cartridge was eluted with 2 mL of methanol con-
taining 0.05% hydrochloric acid. The elute was collected
and evaporated to dryness at 50 °C under a stream of
nitrogen [13]. The evaporated residue was reconstituted
in 50 L of a solution consisting of 2 mL/L ammonium
hydroxide in methanol-water (55:45 by volume). Before
ESI-MS/MS measurement, the reconstituted sample
was applied to an ultra free-MC centrifugal filter unit
(3000 NMWL, Millipore) and centrifuged at 3800 g for
30 min at 4 °C.
Mass Spectrometry
Mass spectra were obtained using an electrospray ion-
ization source on a quadrupole ion trap instrument
Figure 2. MS2 spectra of T3 and rT3 under positive ionization. (a)
For T3, using m/z 651.8 as a precursor ion, the fragment ions are
observed at m/z 634.5, 605.6, and 508.1. (b) For rT3, using m/z 651.8
as a precursor ion, the fragment ions are observed at m/z 634.6,
605.7, and 508.0.
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spray voltage was 3.5 kV. Dry gas (nitrogen) flowed at
5.0 L/min, and the drying temperature was 320 °C.
Samples were introduced by flow injection at 2 L/min.
The mass range scanned was m/z 50–1000. For MS/MS
experimentation, the fragmentation amplitude was set
at 1.0 V, the isolation width was 4.0 m/z. Each mass
spectrum consisted of 25 scans. These same instrument
conditions were used for all standards, mixtures of T3
and rT3, and human serum samples. For quantification,
each standard sample was analyzed a total of eight
times over the period of one week. The mixture sample
of T3 and rT3 was analyzed six times over the period of
one week. Human serum sample was analyzed six
Figure 3. MS2 spectra of T3 and rT3 under negative ionization.
(a) For T3, usingm/z 649.6 as a precursor ion, the fragment ions are
observed atm/z 632.5, 522.9, 506.0, and 478.5. (b) For rT3, usingm/z
649.6 as a precursor ion, the fragment ions are observed at m/z
632.5, 604.4, 478.5, and 463.1.
Table 1. Percentages calculated by solving equations 1 and 2 an
T3 : rT3
Calc. %
1 2 3 4
1:9 10.3 11.6 9.7 11.5
89.7 88.4 90.3 88.5
3:7 28.9 27.8 30.8 28.2
71.1 72.2 69.2 71.8
7:3 70.5 71.3 69.2 70.4
29.5 28.7 30.8 29.6
9:1 87.4 88.7 89.9 87.2
12.6 11.3 10.1 12.8times in one day. The data acquisition software used
was Bruker Daltonics Data Analysis 3.0.
Results and Discussion
Identification of T3 and rT3
Under positive ionization mode, both T3 and rT3 reveal a
singly charged ion [M  H]  at m/z 651.8. Using the T3
MS1 ionm/z 651.8 as a precursor ion, T3MS2 fragment ions
are observed at m/z 634.5, 605.6, and 508.1 (Figure 2a). The
product ion atm/z 634.5 corresponds to [MHNH3]
,
and m/z 605.6 corresponds to [M  H  HCOOH]. For
product ion m/z 508, the 144 Da loss could represent two
possible compositional losses: a loss of HIO or H3IN.
Using the rT3 MS1 ion m/z 651.8 as a precursor ion, rT3
MS2 fragment ions are observed at m/z 634.5, 605.7, and
508.0 (Figure 2b). Although the composition of fragment
ions in the MS2 spectra generated from T3 and rT3 are the
same, the percent ion contributions of each fragment ion
are different. Thus, these MS2 spectra can be used to
identify a single unknown triiodothyronine, because in
each case a “distinguishing product ion”, which has
significantly different abundance compared to other iso-
meric species [23], can be identified. The distinguishing
product ion for T3 is m/z 605.7. Although m/z 605.7 is also
themost abundant ion for rT3, the percent total ion form/z
605.7 is only 42% for rT3, compared to 83% for T3. The
distinguishing product ion for rT3 is m/z 508.0. The
percent total ion for m/z 508.0 is 38% for rT3, compared to
9% for T3. This means that the MS 2 fragment ions at m/z
605.8 and 508.0 could be used to differentiate these two
triiodothyronine isomers.
Under negative ionization mode, both T3 and rT3
reveal a singly charged ion [M  H]  at m/z 649.6. MS2
spectra of m/z 649.6 for T3 and rT3 are shown in Figure
3a and b, respectively. It is obvious that T3 and rT3 each
produce distinguishing product ions, which have sub-
stantially different abundances compared to each other.
In its MS2 spectrum, T3 has a distinguishing product
ion at m/z 632.5, corresponding to [M  H  NH3]
,
which is in much greater abundance (Figure 3a) than
that of the rT3 (Figure 3b). Similarly, in its MS2 spec-
trum, rT3 has a distinguishing product ion at m/z 478.5
(Figure 3b), which is in much greater abundance than
rmalizing the data, as described in the text
Avg.  SD
(n  6) Actual %5 6
8.9 12.4 10.7  1.3 10.0
91.1 87.6 89.3  1.3 90.0
29.3 31.1 29.4  1.3 30.0
70.7 68.9 70.6  1.3 70.0
69.8 68.7 69.9  0.9 70.0
30.2 31.3 30.1  0.9 30.0
86.7 90.6 88.4  1.6 90.0d no13.3 9.4 11.6  1.6 10.0
rT3 
1784 ZHANG ET AL. J Am Soc Mass Spectrom 2005, 16, 1781–1786that of the T3 (Figure 3a). For product ion m/z 478.5, the
171 Da loss could represent a possible compositional
loss: a radical loss of CIO2. However, without extensive
labeling experiments or high-resolution measurements,
this product ion loss cannot be unambiguously as-
signed. Nonetheless, the ion at m/z 478.5 is a predomi-
nant ion in the rT3 spectrum. MS2 experiments reveal
that in the negative ionization mode the distinguishing
Figure 4. MS2 spectra of the mock mixtures of T
 1:9; (b) T3:rT3  3:7; (c) T3:rT3  7:3; (d) T3:product ions for T3 and rT3 are also the most abundantions in their respective spectra. Therefore, for further
quantitative analysis, the ions at m/z 632.5 and 478.5 in
MS2 spectra in negative ionization mode were selected
to represent T3 and rT3, respectively.
Quantification of T3 and rT3
The relative molar percentages of T3 and rT3 isomers in
rT3, under negative ionization mode. (a) T3:rT3
9:1.3 anda mixture were determined using a system of two
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of the pure isomeric triiodothyronine standards, T3 and
rT3, was analyzed eight times by MS2 experiments. The
percent ion contribution of each distinguishing product
ion to the total ion current (TIC) was obtained by
exporting the mass list of the spectrum of interest into
ACD SpecManager. For T3 and rT3, excellent reproduc-
ibility for m/z 632.5 and m/z 478.5 is observed, with
standard deviations of less than 1.5%, respectively.
Using the percent contributions for T3 and rT3, a
system of equations was developed as follows:
70.205A 4.09BC632.5 (1)
8.851A 74.14BC478.5 (2)
C632.5 and C478.5 are the contributions of the ions m/z
632.5 and 478.5 in any given mixture of T3 and rT3. A
and B represent the ratio of T3 and rT3 in the mixture.
To determine the normalization factors, a mixture of T3
and rT3 (1:1) was also analyzed six times in one week.
The percent contribution for each of the product ions,
m/z 632.5 and 478.5 for the 1:1 mixture, is inserted into
the system of equations, solving for A and B (24.165 and
76.92). 50/24.165  2.068  Norm 1 for m/z 632.5;
50/76.92  0.65  Norm 1 for m/z 478.5. This normal-
ization accounts for various factors, including differ-
ences in the isomer’s ionization efficiency [24]. After
normalizing, these values are converted to the calcu-
lated percentages by dividing each value by the sum of
the two values. Thus, the molar percent of T3 and rT3 in
the mixture is obtained.
To demonstrate the utility of the above equations for
quantitative analysis of T3 and rT3, a series of two
component mixtures were prepared with variable con-
centrations of each of the isomers. These were analyzed,
and the percent of each of the isomers in the mixture
was calculated (Table 1).) Figure 4a– d show the MS2
spectra of T3 and rT3 mixtures with various molar
ratios. Clearly, the relative abundance of ion atm/z 632.5
increases with increasing T3 concentration. Conversely,
the relative abundance of ion at m/z 478.5 decreases
with decreasing rT3 concentration. The results reveal
that the quantification procedure works quite effec-
tively for any ratio of T3 and rT3. The error for all of the
samples was very small ( 1.6%), establishing the
utility of this method for quantitative analysis of T3 and
rT3 mixtures.
Application to the Quantitative Analysis
of Human Serum Samples
Having demonstrated the effectiveness of this quantita-
tive analysis method on for T3 and rT3 mixtures, we
applied this method to the analysis of human serum
containing natural levels of thyroxine. Due to the com-
bined reversed-phase and strong anion-exchange char-
acter of the Oasis MAX SPE cartridge, it is well suited
for isolation of acidic substances from serum, such as T4[13]. Because the acidity of T3 and rT3 are very similar
to that of T4, we used Oasis MAX SPE cartridge to
extract T3 and rT3 for direct analysis by ESI-MS/MS.
The results indicate that the present method shows
good reproducibility and precision (Table 2), and that
the molar percents of T3 and rT3 in human serum are
81.5  2.4 and 18.5  2.4, respectively, with a T3/rT3
ratio of 4.5  0.7. This ratio agrees with the ratio in
normal human serum obtained by Santini et al. [25].
Conclusions
Quantification of the molar ratio of T3 to rT3 is an
important initial step toward increased understanding
of the relation between the metabolism and biological
functions of the thyroid hormones. In the present study,
MS2 spectra in either negative ionization mode or
positive ionization mode can be used to differentiate T3
and rT3. MS2 experiments reveal that in the negative
ionization mode the distinguishing product ions for T3
and rT3 are also the most abundant ions in their
respective spectra. Therefore, the ions at m/z 632.5 and
478.5 in MS2 spectra in negative ionization mode were
selected to establish a protocol for quantification of the
T3 and rT3 mixtures. Good precision and accuracy was
demonstrated, and then the protocol was applied to
human serum. The results suggest that the described
method can be used to analyze T3 and rT3 from other
animal sera as well as from human serum.
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